British American Tobacco: The Price Already Assumes Decline
- Current reconciled price $57.65 implies reverse-DCF unlevered cash CAGR of -0.9% at 8.5% WACC, 3% terminal, rising to +2.9% requirement at a 9.5% WACC
- New Categories grew 18.0% CC, GBP1,928m of GBP12,235m group revenue (15.8%); modern oral +65.9% revenue growth, 39.2% volume share, contribution GBP257m
- Current reconciled price $57.65 implies reverse-DCF unlevered cash CAGR of -0.9% at 8.5% WACC, 3% terminal, rising to +2.9% requirement at a 9.5% WACC
- New Categories grew 18.0% CC, GBP1,928m of GBP12,235m group revenue (15.8%); modern oral +65.9% revenue growth, 39.2% volume share, contribution GBP257m
- Restructuring touches ~9,000 roles, targets GBP600m annualized savings by 2028 (GBP500m by 2027); management cuts net finance costs to ~GBP1.65bn and has a GBP1.3bn buyback (~1.4% market value)
Dividend InvestingDividend InvestingConsumer Defensive
GlennGlenn Ford8/272026-08-2711m11 MIN1221223














